Use access key #2 to skip to page content.
$41.72 -0.97 (-2.27%)
5/16/2008 4:00 PM

ImClone Systems, Inc. (IMCL)

CAPS Rating:
***

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

View All Commentary (IMCL)

Recs

0

Avatar mchuley (< 20) Submitted: 1/18/08 5:18 PM : Outperform Start Price: $40.72 IMCL Score: -9.69

i see the stock doubling by end of the year, egg on my face, we will see how i feel by summer, but the data is gonna be a shocker and well thumbs up

Report this Post Replies: 0 | Reply

Featured Broker Partners